1 "New 'Breakthrough' Alzheimer's Drug Approved: Slows Brain Decline By 27%, But $26,500/Year Pricing Controversial Nov 10, 2024
Read More Apparatus Clinical Approval For Colombotide Skb264 (Mk-2870) In Combination With Oxitinib Apr 05, 2025
Read More Disease What Are The Causes Of Nasopharyngeal Carcinoma? What Are The Treatment Options For Nasopharyngeal Carcinoma? Apr 20, 2025
Read More Apparatus World's First Antibody Targeting B7H7 Approved For Clinical Trial In The Us Apr 02, 2025
Read More Apparatus Another Cancer-Independent Targeted Drug Approved! Up To 84% Efficacy! Apr 08, 2025
